Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Pharmacol Res. 2017 Jan 19;119:61–71. doi: 10.1016/j.phrs.2017.01.018

Table 2.

Maternal plasma AUCs of norbuprenorphine (NBUP) and norbuprenorphine-3-β-D-glucuronide (NBUP-G) after retro-orbital injection (1 mg/kg) to pregnant mice on gd 15 over 480 min. Data are reported as mean (95% confidence interval). The NBUP-G/NBUP AUC ratios were calculated based on molar concentrations of NBUP and NBUP-G in maternal plasma. Differences between the analyte AUCs or the AUC ratios of wild-type and Abcb1a-/-/1b-/-or Abcb1a-/-/1b-/-/Abcg2-/- mice were calculated using bootstrapping as described in the Materials and methods section. The p values were corrected for multiple testing using the Bonferroni method.

Parameter Genotype

Wild-type Abcb1a-/-/1b-/- p Abcb1a-/-/1b-/-/Abcg2-/- p
AUC0-480min of NBUP (μg×min×mL-1) 4.1 [3.6, 5.8] 7.1 [6.2, 9.4] < 0.005 8.7 [7.1, 11.3] < 0.005
Fold-change 1.0 1.8 2.2

AUC0-480min of NBUP-G (μg×min×mL-1) 26.8 [21.8, 34.2] 95.0 [75.5,120.8] <0.0001 116.7 [84.4, 154.1] < 0.0001
Fold-change 1.0 3.6 4.4

NBUP-G/NBUP maternal plasma AUC ratio 4.6 [3.7, 5.8] 9.4 [7.1, 11.3] 0.09 9.4 [6.1, 13.5] 0.3
Fold-change 1.0 2.0 2.0